Trxc Stock Buy Or - Sell

: Shareholders at the time of the merger were entitled to receive the $0.35 per share cash payout.

The ticker is no longer active for trading. TransEnterix, the company originally associated with that symbol, rebranded as Asensus Surgical and changed its ticker to ASXC in March 2021. Subsequently, Asensus Surgical was acquired by KARL STORZ and its stock was officially delisted in August 2024. Stock Status and Delisting trxc stock buy or sell

: In March 2021, the company changed its name from TransEnterix to Asensus Surgical to align with its focus on "Performance-Guided Surgery". : Shareholders at the time of the merger

: On August 22, 2024, KARL STORZ finalized its acquisition of Asensus Surgical. Subsequently, Asensus Surgical was acquired by KARL STORZ

: KARL STORZ acquired the company primarily for its Senhance Surgical System and the development of the next-generation LUNA™ System , aiming to integrate these into their global endoscopy portfolio.

Since the company is now , it is not possible to buy or sell shares on public markets.

: As a result of becoming a private subsidiary of KARL STORZ, the common stock has ceased trading on the NYSE American Exchange. Historical Context (TRXC to ASXC)